DK0707477T3 - Anvendelse af Efaxoran og derivater deraf til fremstilling af lægemidler beregnet til behandling af neurodegenerative sygdo - Google Patents
Anvendelse af Efaxoran og derivater deraf til fremstilling af lægemidler beregnet til behandling af neurodegenerative sygdoInfo
- Publication number
- DK0707477T3 DK0707477T3 DK94921698T DK94921698T DK0707477T3 DK 0707477 T3 DK0707477 T3 DK 0707477T3 DK 94921698 T DK94921698 T DK 94921698T DK 94921698 T DK94921698 T DK 94921698T DK 0707477 T3 DK0707477 T3 DK 0707477T3
- Authority
- DK
- Denmark
- Prior art keywords
- derivatives
- efaxoran
- manufacture
- neurodegenerative diseases
- treat neurodegenerative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9308497A FR2707166B1 (fr) | 1993-07-09 | 1993-07-09 | Utilisation de l'efaroxan et de ses dérivés pour la fabrication de médicaments destinés au traitement de maladies neurodégénératives et leur progression . |
PCT/FR1994/000841 WO1995001791A2 (fr) | 1993-07-09 | 1994-07-07 | Utilisation de l'efaroxan et de ses derives pour la fabrication de medicaments destines au traitement des maladies neurodegeneratives |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0707477T3 true DK0707477T3 (da) | 2000-05-15 |
Family
ID=9449128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94921698T DK0707477T3 (da) | 1993-07-09 | 1994-07-07 | Anvendelse af Efaxoran og derivater deraf til fremstilling af lægemidler beregnet til behandling af neurodegenerative sygdo |
Country Status (14)
Country | Link |
---|---|
US (1) | US5661172A (da) |
EP (1) | EP0707477B1 (da) |
JP (1) | JP3494651B2 (da) |
AT (1) | ATE186640T1 (da) |
AU (1) | AU688346B2 (da) |
CA (1) | CA2166781A1 (da) |
DE (1) | DE69421705T2 (da) |
DK (1) | DK0707477T3 (da) |
ES (1) | ES2140544T3 (da) |
FR (1) | FR2707166B1 (da) |
GR (1) | GR3032531T3 (da) |
NZ (1) | NZ268914A (da) |
PT (1) | PT707477E (da) |
WO (1) | WO1995001791A2 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2752163B1 (fr) * | 1996-08-12 | 1998-10-30 | Pf Medicament | Utilisation de l'efaroxan pour la fabricaton de medicament destine au traitement de la maladie de huntington |
TWI251813B (en) * | 2001-11-09 | 2006-03-21 | Via Tech Inc | Method for protecting phase lock loop in optical data-reading system |
US8188126B2 (en) * | 2002-05-16 | 2012-05-29 | Pierre Fabre Medicament | Imidazolic compounds and use thereof as alpha-2 adrenergic receptors |
US9107917B2 (en) * | 2005-05-13 | 2015-08-18 | The Feinstein Institute For Medical Research | Treatment of sepsis and inflammation with alpha2A adrenergic antagonists |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZW13782A1 (en) * | 1981-07-28 | 1982-10-06 | Reckitt & Colmann Prod Ltd | Imidazoline derivatives |
US4855308A (en) * | 1987-12-04 | 1989-08-08 | Warner-Lambert Company | Method of treating senile cognitive decline with N'-substituted aminopyridine adrenergic agents |
US4855385A (en) * | 1988-06-22 | 1989-08-08 | The Dow Chemical Company | Monocarboxylic acid derivatives of aliphatic based epoxy resins |
FR2669030B1 (fr) * | 1990-11-14 | 1992-12-31 | Adir | Nouveaux derives d'imidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
-
1993
- 1993-07-09 FR FR9308497A patent/FR2707166B1/fr not_active Expired - Fee Related
-
1994
- 1994-07-07 WO PCT/FR1994/000841 patent/WO1995001791A2/fr active IP Right Grant
- 1994-07-07 AT AT94921698T patent/ATE186640T1/de not_active IP Right Cessation
- 1994-07-07 DE DE69421705T patent/DE69421705T2/de not_active Expired - Fee Related
- 1994-07-07 CA CA002166781A patent/CA2166781A1/fr not_active Abandoned
- 1994-07-07 EP EP94921698A patent/EP0707477B1/fr not_active Expired - Lifetime
- 1994-07-07 DK DK94921698T patent/DK0707477T3/da active
- 1994-07-07 US US08/581,516 patent/US5661172A/en not_active Expired - Fee Related
- 1994-07-07 JP JP50386595A patent/JP3494651B2/ja not_active Expired - Fee Related
- 1994-07-07 NZ NZ268914A patent/NZ268914A/xx unknown
- 1994-07-07 ES ES94921698T patent/ES2140544T3/es not_active Expired - Lifetime
- 1994-07-07 AU AU72308/94A patent/AU688346B2/en not_active Ceased
- 1994-07-07 PT PT94921698T patent/PT707477E/pt unknown
-
2000
- 2000-02-02 GR GR20000400227T patent/GR3032531T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU7230894A (en) | 1995-02-06 |
GR3032531T3 (en) | 2000-05-31 |
JPH08512305A (ja) | 1996-12-24 |
EP0707477A1 (fr) | 1996-04-24 |
FR2707166B1 (fr) | 1995-09-29 |
WO1995001791A3 (fr) | 1995-03-09 |
CA2166781A1 (fr) | 1995-01-19 |
NZ268914A (en) | 1999-06-29 |
DE69421705T2 (de) | 2000-06-29 |
WO1995001791A2 (fr) | 1995-01-19 |
JP3494651B2 (ja) | 2004-02-09 |
US5661172A (en) | 1997-08-26 |
ES2140544T3 (es) | 2000-03-01 |
DE69421705D1 (de) | 1999-12-23 |
AU688346B2 (en) | 1998-03-12 |
ATE186640T1 (de) | 1999-12-15 |
EP0707477B1 (fr) | 1999-11-17 |
PT707477E (pt) | 2000-04-28 |
FR2707166A1 (fr) | 1995-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1346041T3 (da) | Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom | |
ATE144420T1 (de) | Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen | |
DE69533040D1 (de) | Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien | |
NO20053855D0 (no) | 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer. | |
ATE200672T1 (de) | Alkoxyalkylcarbamate von imidazo(1,2-a)pyridinen | |
DE69725879D1 (de) | VERWENDUNG VON p-AMINOPHENOLDERIVATEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN | |
CY1105545T1 (el) | Θεραπεια στατινης για ενισχυση της διατηρησης νοητικης λειτουργιας | |
DK0707477T3 (da) | Anvendelse af Efaxoran og derivater deraf til fremstilling af lægemidler beregnet til behandling af neurodegenerative sygdo | |
NO984651D0 (no) | Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet | |
DK0703781T3 (da) | Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom | |
ATE143946T1 (de) | N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten | |
DK0808306T3 (da) | Hidtil ukendte pyridin- eller pyridazinderivater, fremgangsmåder til fremstilling deraf og lægemidler indeholdende disse fo | |
ATE168697T1 (de) | Pyrrolidinderivate zur behandlung von cck und gastrin-abhängigen erkrankungen |